AXSM Axsome Therapeutics, Inc.
Price Chart
Executive Summary
A cluster of insider sales at Axsome Therapeutics (AXSM) over the past week totaled ~$20.2M in open-market transactions, led by CEO Herriot Tabuteau ($12.0M) and CFO Nick Pizzie ($7.9M). Director-level sales were minor. At 0.16% of market cap, the selling is modest and likely reflects planned exercises and diversification rather than a bearish signal.
Key Financial Metrics
Actionable Insight
The insider selling, while notable in absolute dollars, is moderate relative to market cap and appears tied to option exercises. No bearish read-through is warranted. Monitor for any upcoming corporate announcements or earnings that could provide context for why key executives executed sales at this juncture.
Key Facts
- CEO sold 49,670 shares at $241.01 for $11.97M on June 9.
- CFO sold 33,000 shares at $240.09 for $7.92M on June 9.
- Three directors sold aggregate ~$304K in small lots.
- Total open-market selling cluster value: ~$20.2M (0.16% of $12.7B market cap).
- All CEO and CFO sales followed derivative exercises (non-cash), consistent with planned transactions.
- No material corporate news or catalyst identified in the filing window.
Financial Impact
~$20.2M in insider open-market sales over 2 days, representing 0.16% of market cap — modest and routine.
Risk Factors
- If future filings reveal a lack of pre-arranged trading plans, the selling could indicate reduced confidence.
- Continued insider selling at current levels might pressure sentiment among retail holders.
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-AXSM-1781224472996 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 12, 2026
1d ago
|
Insider Cluster
| $253.88 awaiting T+1 | awaiting T+1 | — | $255.17 (+0.51%) |
|
Jun 11, 2026
1d ago
|
144
| $253.88 awaiting T+1 | awaiting T+1 | — | $255.17 (+0.51%) |
|
Jun 11, 2026
2d ago
|
Insider Cluster
| $246.42 awaiting T+1 | awaiting T+1 | — | $255.17 (+3.55%) |
|
Jun 9, 2026
3d ago
|
144
| $245.68 awaiting T+1 | awaiting T+1 | — | $255.17 (+3.86%) |
|
Jun 9, 2026
3d ago
|
8-K
| $245.68 awaiting T+1 | awaiting T+1 | — | $255.17 (+3.86%) |
|
Jun 9, 2026
3d ago
|
Insider Cluster
| $245.68 awaiting T+1 | awaiting T+1 | — | $255.17 (+3.86%) |
|
Jun 4, 2026
9d ago
|
Press Release
| $231.48 $232.32 | ▲ +0.36% | ▲ +2.96% | $255.17 (+10.23%) |
|
Jun 3, 2026
10d ago
|
8-K
| $233.49 $231.48 | ▼ −0.86% | ▼ −1.26% | $255.17 (+9.29%) |
|
May 4, 2026
5w ago
|
8-K
| $223.70 $223.06 | ▼ −0.29% | ▼ −1.08% | $255.17 (+14.07%) |
|
May 4, 2026
5w ago
|
Press Release
| $223.70 $223.06 | ▼ −0.29% | ▼ −1.08% | $255.17 (+14.07%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access